| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 2.294 | 0 | 0 | 0 | 0 | 0 | 427 | 3.015 |
| Total Income - EUR | 0 | 0 | 2.294 | 0 | 0 | 0 | 0 | 0 | 427 | 3.015 |
| Total Expenses - EUR | 1.676 | 3.589 | 4.271 | 5.611 | 7.213 | 1.414 | 3.739 | 8.349 | 7.657 | 10.296 |
| Gross Profit/Loss - EUR | -1.676 | -3.589 | -1.977 | -5.611 | -7.213 | -1.414 | -3.739 | -8.349 | -7.231 | -7.281 |
| Net Profit/Loss - EUR | -1.676 | -3.589 | -2.000 | -5.611 | -7.213 | -1.414 | -3.739 | -8.349 | -7.235 | -7.311 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Carmedi Beyonce Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 154 | 152 | 150 | 147 | 144 | 141 | 138 | 139 | 138 | 138 |
| Current Assets | 0 | 15 | 0 | 50 | 1 | 48 | 35 | 352 | 4.060 | 511 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 0 | 15 | 0 | 50 | 1 | 48 | 35 | 352 | 4.060 | 511 |
| Shareholders Funds | -12.865 | -16.323 | -18.046 | -23.326 | -30.087 | -30.931 | -33.984 | -42.438 | -49.544 | -56.578 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 13.019 | 16.490 | 18.196 | 23.524 | 30.232 | 31.120 | 34.156 | 42.929 | 53.742 | 57.226 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "1421 - 1421" | |||||||||
| CAEN Financial Year |
1413
|
|||||||||
Comments - Carmedi Beyonce Srl